A case report of Tangier disease presents with acute sensorimotor polyneuropathy and its treatment approach

被引:2
|
作者
Karabudak, Saniye [1 ]
Guzel, Vildan [1 ]
Guler, Beril [2 ]
Uyanik, Bulent [3 ]
Guersoy, Azize Esra [4 ]
机构
[1] Bezmialem Vakif Univ, Fac Med, Dept Neurol, Istanbul, Turkiye
[2] Bezmialem Vakif Univ, Fac Med, Dept Pathol, Istanbul, Turkiye
[3] Bezmialem Vakif Univ, Fac Med, Dept Genet, Istanbul, Turkiye
[4] Basaksehir Cam Sakura Hosp, Dept Neurol, Istanbul, Turkiye
关键词
Tangier disease; Miglustat; Polyneuropathies; Cholesterol esters; GENE; MUTATIONS;
D O I
10.1016/j.jacl.2023.11.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polyneuropathy is a frequently encountered clinical presentation where peripheral nerves are affected due to the same cause and physiopathological processes. We report a case of acute sensorimotor polyneuropathy in a patient with Tangier disease (TD) who was treated with miglustat which is a glycosphingolipid synthesis inhibitor. TD is a very rare genetic disorder caused by mutations in the ATP-binding cassette transporter A1 (ABCA1) gene which encodes the cholesterol efflux regulatory protein. It leads to accumulation of cholesterol esters within various tissues and affects lipid metabolism by deficiency of high-density lipoprotein (HDL) in the blood. Due to the accumulation of cholesterol esters in Schwann cells, it could provoke polyneuropathy in TD. Our case presented to our clinic with quadriparesis and after treated with miglustat therapy his weakness regressed. (c) 2023 National Lipid Association. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:e285 / e289
页数:5
相关论文
共 50 条